Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010)
Compugen (CGEN) posted quarterly Depreciation & Amortization (CF) of $50000.0 for Q4 2010, up 316.67% year-over-year from $12000.0 in Q4 2009, and down 1.96% on a QoQ basis from $51000.0 in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010) Analysis & Trends
Compugen has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $50000.0 in Q4 2010.
- Depreciation & Amortization (CF) for Q4 2010 came in at $50000.0, up 316.67% year-over-year; the trailing twelve-month figure through Sep 2011 was $50000.0 (down 20.63% YoY), and the FY2025 annual result was $475000.0, down 2.26% from the prior year.
- Depreciation & Amortization (CF) eased to $50000.0 in Q4 2010, from $51000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $51000.0 in Q3 2010 and troughed at $12000.0 in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 50,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Sep 30, 2009 | 48,000.00 |